Literature DB >> 7041590

Effects of captopril on prostaglandin and natriuresis in patients with essential hypertension.

A Hornych, M Safar, A Simon, J Levenson, J Bariety, P Milliez.   

Abstract

The antihypertensive, renal and hormonal effects of captopril were studied in 10 patients with essential hypertension. Captopril significantly decreased arterial blood pressure with a concomitant increase in glomerular filtration rate, natriuresis and kaliuresis and a significant selective increase in urinary (renal) prostaglandin E2; other plasma and urinary prostaglandin (F2 alpha, 6-keto-prostaglandin F1 alpha; thromboxane B2) were not significantly changed. The urinary prostaglandin E2 increase was observed even in patients with pretreatment subnormal prostaglandin E2 excretion. Increases in urinary prostaglandin E2 were significantly positively correlated with increases in urinary sodium concentration. It is concluded that the antihypertensive effect of captopril is mediated, at least partially, by prostaglandin E2 release from renal and extrarenal tissues. Captopril enhances natriuresis at a lower perfusion pressure.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7041590     DOI: 10.1016/0002-9149(82)90376-9

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  3 in total

Review 1.  Captopril. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.

Authors:  R N Brogden; P A Todd; E M Sorkin
Journal:  Drugs       Date:  1988-11       Impact factor: 9.546

Review 2.  Angiotensin I converting enzyme inhibitors and the renal excretion of urate.

Authors:  W P Leary; A J Reyes
Journal:  Cardiovasc Drugs Ther       Date:  1987       Impact factor: 3.727

3.  Angiotensin converting enzyme inhibitors (captopril, CGS14831 and CGS14824A) antagonise in vitro smooth muscle prostanoid synthesis: evidence for calcium channel blockade.

Authors:  J Y Jeremy; D P Mikhailidis; P Dandona
Journal:  Agents Actions       Date:  1988-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.